Vyome
HIND | NASDAQ
$1.53
-$0.05 (-3.16%)
At close: Nov 16, 2026, 4:00 PM ET
$1.55
+$0.02 (+1.31%)
After-hours:
Nov 16, 2026, 7:40 PM ET
-3.16%
(1D)Rating
51.5
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #250/1021 (Top 24%)
Key Statistics
Market Data
Market Cap $10.74M
1D Range
1.50 1.65
52W Range
1.50 5.73
Valuation (TTM)
PE -2.51
PB 2.02
EV/EBITDA -1.06
Valuation (NTM)
Forward PE N/A
Forward PEG 0.03
Price Target $3.50
Cash Flow
FCF Yield -41.4%
SBC Adj. FCF Yield -44.1%
SBC Impact -6.5%
Margins
Gross Margin 47.0%
Operating Margin -2853.6%
FCF Margin -2905.5%
Growth (CAGR)
Revenue 3Y | 5Y -75.0% |
-59.3%
Dil EPS 3Y | 5Y 122.8% |
90.6%
FCF 3Y | 5Y 19.3% |
47.4%
Returns
ROA -43.6%
ROE -73.1%
ROIC -63.3%
Financial Health
Net Cash
$6.61M
Current Ratio 3.68
Interest Coverage -229.34
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflamm...
Sector Healthcare
Industry Biotechnology
Employees 18
IPO Date Oct 6, 2016
Website www.vyometx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.13
Beat +27.78%
YoY:
+95.83% REV
$58K
Miss -42.00%
YoY:
+67.49%Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove HIND